Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · BeyondSpring Inc. (BYSI)

BeyondSpring completes Sept. 30 sale of subsidiary to Biolin; no cash paid

Mixed Impact 4 of 5 m&a Written later

BeyondSpring completed the sale of BeyondSpring Ltd., which indirectly holds its interest in Bulin, to Biolin Investment Limited on September 30, 2026. The Company received no cash; the buyer's consideration is a commitment to fund the China portion of the DUBLIN-4 Phase 3 trial and a license to the resulting data. The Company no longer controls the disposed entities or SEED Therapeutics, and the pro forma figures show a preliminary gain of $53.7 million that is not yet final.

Key points

  • No cash consideration was paid or payable at closing on September 30, 2026
  • Non-cash consideration: the Investor's obligation to fund and complete the China portion of DUBLIN-4, plus a license to the trial data
  • Preliminary pro forma gain on disposition of $53.7 million (about $53,677 thousand); excludes contingent consideration and may differ materially
  • After the sale, the Company retained about 29% of SEED's voting power on an as-converted basis but no control of SEED

The filing

CompanyBeyondSpring Inc. (BYSI)
Form8-K, current report
Filed with the SECOct 6, 2026, 4:30 PM ET
Accession number0001171843-26-006465

Items reported: 2.01 Acquisition or Disposition Completed

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.